BAM
COLL icon

Barrett Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Barrett Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-277
Closed -$5K – 347
2016
Q1 		$5K Buy
+277
New +$5.04K ﹤0.01% 349

Other funds holding COLL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrett Asset Management's COLL Position: Q2 2016 in Review

Barrett Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2016, closing a stake of 277 shares — an estimated $5K sold.

Barrett Asset Management first reported a position in COLL in Q1 2016 and held it in 1 quarter. The position peaked at $5K in Q1 2016. 73 funds tracked by Wall St. Rank hold COLL as of Q2 2016.

  • Barrett Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2016 after selling out during the quarter.
  • Barrett Asset Management sold 277 Collegium Pharmaceutical shares in Q2 2016, an estimated $5K.
  • Barrett Asset Management first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 1 quarter.
  • Barrett Asset Management's Collegium Pharmaceutical position peaked at $5K in Q1 2016.
  • 73 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2016.

Based on Barrett Asset Management's 13F filing for Q2 2016, filed 18 Jul 2016.